KRISTEN BRENNAN: Open Payments
NPI 1982309829 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 101 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $477 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $229 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $170 |
| Ardelyx, Inc. | 7 | $164 |
| Janssen Biotech, Inc. | 7 | $141 |
| Celltrion USA Inc. | 5 | $129 |
| Daiichi Sankyo Inc. | 3 | $83 |
| QOL Medical, LLC | 3 | $75 |
| Aimmune Therapeutics, Inc. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
Products named: RINVOQ, ENTYVIO, XIFAXAN, IBSRELA, TREMFYA, VEGZELMA, DUPIXENT, INJECTAFER.
Industry payments across PA — which companies pay providers there.
